dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
Pivotal Study of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema (DIAMOND-2) (clinicaltrials.gov) - Nov 4, 2024 - P3 | N=350 | Recruiting | Sponsor: Oculis | Trial completion date: Dec 2025 ➔ Jun 2026 | Initiation date: Dec 2023 ➔ Mar 2024 | Trial primary completion date: Dec 2025 ➔ Jun 2026 
Trial completion date • Trial initiation date • Trial primary completion date • Diabetic Macular Edema • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT06172257
 
Nov 4, 2024
 
Prev Next